Xontogeny

Investor type Accelerator
Founders Chris Garabedian

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 5
Portfolio companies 5
Rounds per year 0.83
Lead investments 0
Key employees Soon
Stages of investment
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Biopharma
  • Therapeutics
  • Medical

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
37 Interactive Entertainment China, Shanghai
Abercross Holdings England, London, United Kingdom
Bhatia Funds -
Crown Battery Fremont, Ohio, United States
Divine interVentures California, Oakland, United States
Foster & Foster Florida, Fort Myers, United States
Fukushima Bank Fukushima, Fukushima Prefecture, Japan
GMG Capital Partners New York, New York, United States
Hainan Yedao China, Haikou, Hainan
Harwick Overseas -
Jaipuria Group -
London Seed Capital England, London, United Kingdom
Marshmallow Japan, Tokyo
MSC Group Japan, Tokyo
MYOB Australia, Glen Waverley, Victoria
Myriad Group Switzerland, Zürich, Zurich
OneMain Financial Baltimore, Maryland, United States
Rowan Dartington Bristol, England, United Kingdom
Sinofaith intellectual Property China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

PolyCore Therapeutics

Health Care
Professional Services
Therapeutics
11 Apr 2022 Philadelphia, Pennsylvania, United States

Nephraegis Therapeutics

Biopharma
Health Care
Medical
Therapeutics
12 May 2021 Illinois, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Xontogeny?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: